Cocaine vaccine trials
The effectiveness of a vaccine designed to treat cocaine addiction will soon be tested in a trial in the US. The vaccine, called TA-CD and owned by Xenova of Slough in the UK, is designed to stimulate production of antibodies that bind to the drug, blocking its effect. The trial will involve over 100 addicts. Safety trials have already been done.
Rush to contain polio
A polio outbreak in Nigeria has spread to neighbouring countries, threatening the programme to eradicate the disease worldwide. Nearly a dozen children have been left paralysed in Burkina Faso, Ghana, Niger and…
